Hong-Guang Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hong-Guang Xu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Zhou-Shan Tao
Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China
4 shared publications- Min Yang
Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China.
3 shared publications Wan-Shu Zhou
Department of Geriatrics, The Second Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 10, Rehabilitation Road, 241001, Wuhu, Anhui, China
2 shared publicationsXing-Jing Wu
Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Anhui, People's Republic of China
2 shared publicationsYang Li
Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China
2 shared publicationsHan-Li Lu
Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China
1 shared publication
Latest Publications
- 27 February 2022
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 36 (10) , 1775-1785
Local treatment with Sema3a could promote the osseointegration of hydroxyapatite coated titanium rod in diabetic rats
Recently, semaphorin 3A (Sema3A) has been identified as a critical gene for osteogenic differentiation of mesenchymal stem cells and increases osteoblastic bone formation. However, in current research studies, there is a lack of focus on whether Sema3a can affect the osseointegration of titanium rods in diabetes and through what biological mechanisms. Therefore, the present work was aimed to evaluate the effect of local administration with Sema3A on hydroxyapatite coated titanium rod osseointegration in diabetic rat model and preliminary exploration of possible mechanisms. The MC3T3-E1 cells were co-cultured with Sema3A and high glucose and induced to osteogenesis, and the cell viability, osteogenic activity was observed by Cell Counting Kit-8(CCK-8), Alkaline Phosphatase staining, Alizarin Red Staining, and Western Blot. In vitro experiments, CCK-8, ALP, and ARS staining results show that the mineralization and osteogenic activity of MC3T3-E1increased significantly after intervention by Sema3A, as well as a higher levels of protein expressions including Runt-Related Transcription Factor 2, silent mating type information regulation 2 homolog-1(SIRT1), catalase (CAT), superoxide dismutase 1 (SOD1), and superoxide dismutase 2 (SOD2). In vivo experiment, a better stability and osseointegration of the titanium rod were observed after treatment with Sema3A, as well as a higher SOD1, SOD2, CAT, and SIRT1 gene expression. The present study indicates that local treatment with Sema3A was associated with increased osseointegration of titanium rod by reducing the oxidative stress of osteoblasts and enhancing the function of osteoblasts in a diabetic rat.
- 27 February 2022
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 36 (10) , 1775-1785
Local treatment with Sema3a could promote the osseointegration of hydroxyapatite coated titanium rod in diabetic rats
Recently, semaphorin 3A (Sema3A) has been identified as a critical gene for osteogenic differentiation of mesenchymal stem cells and increases osteoblastic bone formation. However, in current research studies, there is a lack of focus on whether Sema3a can affect the osseointegration of titanium rods in diabetes and through what biological mechanisms. Therefore, the present work was aimed to evaluate the effect of local administration with Sema3A on hydroxyapatite coated titanium rod osseointegration in diabetic rat model and preliminary exploration of possible mechanisms. The MC3T3-E1 cells were co-cultured with Sema3A and high glucose and induced to osteogenesis, and the cell viability, osteogenic activity was observed by Cell Counting Kit-8(CCK-8), Alkaline Phosphatase staining, Alizarin Red Staining, and Western Blot. In vitro experiments, CCK-8, ALP, and ARS staining results show that the mineralization and osteogenic activity of MC3T3-E1increased significantly after intervention by Sema3A, as well as a higher levels of protein expressions including Runt-Related Transcription Factor 2, silent mating type information regulation 2 homolog-1(SIRT1), catalase (CAT), superoxide dismutase 1 (SOD1), and superoxide dismutase 2 (SOD2). In vivo experiment, a better stability and osseointegration of the titanium rod were observed after treatment with Sema3A, as well as a higher SOD1, SOD2, CAT, and SIRT1 gene expression. The present study indicates that local treatment with Sema3A was associated with increased osseointegration of titanium rod by reducing the oxidative stress of osteoblasts and enhancing the function of osteoblasts in a diabetic rat.
- 28 November 2019
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 53 (7) , 671-678
Rapamycin could increase the effects of melatonin against age-dependent bone loss
Previous studies have demonstrated the beneficial effect of melatonin (MEL) on bone tissue and bone metabolism. Rapamycin (RAP) promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration; however, reports about effects of RAP on bone loss for aged female rats with MEL administration are limited. This study investigated the impact of treatment with RAP on bone loss for aged female rats with MEL administration. Female Sprague-Dawley rats weighing approximately 520 g were randomly divided into 3 groups of 10: group CON, group MEL and group MEL + RAP and received saline, MEL, RAP plus MEL treatment until death at 12 weeks, respectively. The results of maintaining bone mass and bone strength with RAP plus MEL administration were evaluated by histology, microcomputerized tomography (Micro-CT), gene expression analysis and biomechanical testing. Results from this study indicated that MEL + RAP had stronger effects on the prevention and treatment of osteoporosis than MEL administration. Administration of MEL + RAP produced the strongest effects on bone parameters and strength for distal femurs and regulation of OPG/RANKL signalling pathway-related gene expression. These results seemed to indicate that RAP could increase the effects of MEL on age-dependent bone loss. Frühere Studien haben die positive Wirkung von Melatonin (MEL) auf das Knochengewebe und den Knochenstoffwechsel gezeigt. Rapamycin (RAP) fördert die Osteoblastenproliferation, hemmt die Osteoklastenproliferation und wirkt sich positiv auf die Knochenregeneration aus. Berichte über die Auswirkungen von RAP auf den Knochenverlust bei älteren weiblichen Ratten mit MEL-Verabreichung sind jedoch begrenzt. Diese Studie untersuchte die Auswirkungen der RAP-Behandlung auf den Knochenabbau bei älteren weiblichen Ratten mit MEL-Gabe. Weibliche Sprague-Dawley-Ratten mit einem Gewicht von ca. 520 g wurden in 3 Gruppen randomisiert: Gruppe CON, Gruppe MEL und Gruppe MEL + RAP. Sie erhielten eine Behandlung mit entweder Kochsalzlösung, MEL- oder RAP plus MEL bis zum Tod nach 12 Wochen. Die Ergebnisse der Erhaltung der Knochenmasse und Knochenstärke mit der Verabreichung von MEL + RAP wurden durch Histologie, Mikro-Computertomographie (Mikro-CT), Genexpressionsanalyse und biomechanische Tests bewertet. Die Ergebnisse dieser Studie zeigten, dass MEL + RAP stärkere Auswirkungen auf die Prävention und Behandlung von Osteoporose hatte als die Gabe von MEL. Die Verabreichung von MEL + RAP hatte die stärksten Auswirkungen auf die Knochenparameter sowie die Festigkeit des distalen Femurs und die Regulation der OPG/RANKL-Signalweg-bezogenen Genexpression. Diese Ergebnisse schienen darauf hinzudeuten, dass RAP die Auswirkungen von MEL auf den altersbedingten Knochenabbau verstärken könnte.
- 28 November 2019
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 53 (7) , 671-678
Rapamycin could increase the effects of melatonin against age-dependent bone loss
Previous studies have demonstrated the beneficial effect of melatonin (MEL) on bone tissue and bone metabolism. Rapamycin (RAP) promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration; however, reports about effects of RAP on bone loss for aged female rats with MEL administration are limited. This study investigated the impact of treatment with RAP on bone loss for aged female rats with MEL administration. Female Sprague-Dawley rats weighing approximately 520 g were randomly divided into 3 groups of 10: group CON, group MEL and group MEL + RAP and received saline, MEL, RAP plus MEL treatment until death at 12 weeks, respectively. The results of maintaining bone mass and bone strength with RAP plus MEL administration were evaluated by histology, microcomputerized tomography (Micro-CT), gene expression analysis and biomechanical testing. Results from this study indicated that MEL + RAP had stronger effects on the prevention and treatment of osteoporosis than MEL administration. Administration of MEL + RAP produced the strongest effects on bone parameters and strength for distal femurs and regulation of OPG/RANKL signalling pathway-related gene expression. These results seemed to indicate that RAP could increase the effects of MEL on age-dependent bone loss. Frühere Studien haben die positive Wirkung von Melatonin (MEL) auf das Knochengewebe und den Knochenstoffwechsel gezeigt. Rapamycin (RAP) fördert die Osteoblastenproliferation, hemmt die Osteoklastenproliferation und wirkt sich positiv auf die Knochenregeneration aus. Berichte über die Auswirkungen von RAP auf den Knochenverlust bei älteren weiblichen Ratten mit MEL-Verabreichung sind jedoch begrenzt. Diese Studie untersuchte die Auswirkungen der RAP-Behandlung auf den Knochenabbau bei älteren weiblichen Ratten mit MEL-Gabe. Weibliche Sprague-Dawley-Ratten mit einem Gewicht von ca. 520 g wurden in 3 Gruppen randomisiert: Gruppe CON, Gruppe MEL und Gruppe MEL + RAP. Sie erhielten eine Behandlung mit entweder Kochsalzlösung, MEL- oder RAP plus MEL bis zum Tod nach 12 Wochen. Die Ergebnisse der Erhaltung der Knochenmasse und Knochenstärke mit der Verabreichung von MEL + RAP wurden durch Histologie, Mikro-Computertomographie (Mikro-CT), Genexpressionsanalyse und biomechanische Tests bewertet. Die Ergebnisse dieser Studie zeigten, dass MEL + RAP stärkere Auswirkungen auf die Prävention und Behandlung von Osteoporose hatte als die Gabe von MEL. Die Verabreichung von MEL + RAP hatte die stärksten Auswirkungen auf die Knochenparameter sowie die Festigkeit des distalen Femurs und die Regulation der OPG/RANKL-Signalweg-bezogenen Genexpression. Diese Ergebnisse schienen darauf hinzudeuten, dass RAP die Auswirkungen von MEL auf den altersbedingten Knochenabbau verstärken könnte.
- 22 November 2019
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (7) , 1009-1018
Local administration of aspirin improves osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats through activation of the Notch signaling pathway
Osteoporosis-induced impaired bone regeneration would result in compromised osseointegration of hydroxyapatite-coated titanium and high rate of implant failure. Local administration of aspirin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration in osteoporotic condition. We hypothesized that reduced osteogenesis may account for poor osseointegration of hydroxyapatite-coated titanium which could be ameliorated by using local aspirin. The aim of this study was to confirm the effect of the local incorporation of aspirin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague–Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group Sham, group OVX and group OVX + ASP, and the rats from OVX and Sham received hydroxyapatite-coated implants and animals belong to group OVX + ASP received aspirin-hydroxyapatite-coated implants until death at 12 weeks, respectively. After 12-week healing period, local treatment with aspirin revealed improved osseointegration compared to OVX, with significant improvement of the bone area ratio and bone-to-implant contact in histomorphometry, the bone mass and trabecular architecture in micro-CT evaluation, and the maximal push-out force in push out test. Moreover, group OVX + ASP presented the strongest effect on Jagged1, Notch1, and Hes-1(P < 0.05). These results demonstrated that local administration of aspirin could enhance hydroxyapatite-coated titanium implant osseointegration in OVX rats by activation Wnt signaling pathway to improve implant fixation in osteoporotic bone.
- 22 November 2019
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (7) , 1009-1018
Local administration of aspirin improves osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats through activation of the Notch signaling pathway
Osteoporosis-induced impaired bone regeneration would result in compromised osseointegration of hydroxyapatite-coated titanium and high rate of implant failure. Local administration of aspirin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration in osteoporotic condition. We hypothesized that reduced osteogenesis may account for poor osseointegration of hydroxyapatite-coated titanium which could be ameliorated by using local aspirin. The aim of this study was to confirm the effect of the local incorporation of aspirin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague–Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group Sham, group OVX and group OVX + ASP, and the rats from OVX and Sham received hydroxyapatite-coated implants and animals belong to group OVX + ASP received aspirin-hydroxyapatite-coated implants until death at 12 weeks, respectively. After 12-week healing period, local treatment with aspirin revealed improved osseointegration compared to OVX, with significant improvement of the bone area ratio and bone-to-implant contact in histomorphometry, the bone mass and trabecular architecture in micro-CT evaluation, and the maximal push-out force in push out test. Moreover, group OVX + ASP presented the strongest effect on Jagged1, Notch1, and Hes-1(P < 0.05). These results demonstrated that local administration of aspirin could enhance hydroxyapatite-coated titanium implant osseointegration in OVX rats by activation Wnt signaling pathway to improve implant fixation in osteoporotic bone.
- 21 August 2019
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 53 (6) , 538-545
Resveratrol reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats
Previous studies have demonstrated the damaging effect of alcohol (ALH) consumption on bone tissue and bone metabolism. Resveratrol (RES) promotes osteoblast proliferation and inhibits osteoclast proliferation and positively affects bone regeneration; however, reports about effects of RES on osseointegration in aged female rats with ALH consumption are limited. This study was designed to investigate the impact of treatment with RES on osseointegration for aged female rats with ALH consumption. This study included 30 female Sprague-Dawley rats (22 months old), weighing approximately 520 g. All animals were randomly divided into 3 groups of 10: a control group (CON) receiving saline, a group receiving ALH and a group receiving ALH + RES until death after 12 weeks. The results of enhanced osseointegration in senile female rats with RES consumption were evaluated by histology, microcomputerized tomography (micro-CT), gene expression analysis and a biomechanical test. The results of this study indicated that ALH + RES showed stronger effects on the improvement of osseointegration in senile female rats with ALH consumption. The ALH + RES produced stronger effects on bone volume per total volume (BV/TV), mean trabecular thickness (Tb.Th), mean trabecular number (Tb.N) and mean trabecular separation (Tb.Sp), connective tissue density (Conn.D) and maximum push-out force for implants, and regulation of osteogenesis and bone resorption-related gene expression. These results seem to indicate that RES intervention reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats with ALH consumption. Bereits publizierte Studien belegen den schädlichen Effekt von Alkoholkonsum auf das Knochengewebe und den Knochenstoffwechsel. Resveratrol (RES) fördert die Osteoblastenproliferation und hemmt die Osteoklastenproliferation, zudem hat es positiven Einfluss auf die Knochenregeneration; die Datenlage zu Effekten von RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum ist jedoch limitiert. In der vorliegenden Studie sollte der Einfluss einer Behandlung mit RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum untersucht werden. Eingeschlossen wurden 30 weibliche Sprague-Dawley-Ratten (22 Monate alt) mit einem Gewicht von ungefähr 520 g. Alle Tiere wurden in drei Gruppen mit je 10 Individuen randomisiert; eine Kontrollgruppe (CON) erhielt Salzlösung, eine zweite Gruppe Alkohol und eine dritte Alkohol + RES bis zum Tod nach 12 Wochen. Die Resultate einer verstärkten Osseointegration bei alten weiblichen Ratten mit RES-Einnahme wurden mittels histologischer Untersuchung, Mikrocomputertomographie (Mikro-CT), Genexpressionsanalyse und eines biomechanischen Tests überprüft. In dieser Studie wurden unter Alkohol + RES stärkere Effekte auf die Verbesserung der Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum beobachtet. Alkohol + RES hatte stärkere Effekte auf Knochenvolumen pro Gesamtvolumen (BV/TV), Trabekeldicke (Tb.Th), Trabekelzahl (Tb.N), Trabekelabstand (Tb.Sp), die mittlere Bindegewebsdichte (Conn.D), die Push-out-Kraft für Implantate sowie die Regulierung der osteogenese- und knochenresorptionsbezogenen Genexpression. Diese Ergebnisse deuten darauf hin, dass eine RES-Intervention die negative Wirkung von Alkohol auf die Osseointegration hydroxylapatitbeschichteter Implantate bei alten weiblichen Ratten mit Alkoholkonsum umkehrt.
- 21 August 2019
- Published by Springer Nature in Zeitschrift für Gerontologie und Geriatrie
- Vol. 53 (6) , 538-545
Resveratrol reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats
Previous studies have demonstrated the damaging effect of alcohol (ALH) consumption on bone tissue and bone metabolism. Resveratrol (RES) promotes osteoblast proliferation and inhibits osteoclast proliferation and positively affects bone regeneration; however, reports about effects of RES on osseointegration in aged female rats with ALH consumption are limited. This study was designed to investigate the impact of treatment with RES on osseointegration for aged female rats with ALH consumption. This study included 30 female Sprague-Dawley rats (22 months old), weighing approximately 520 g. All animals were randomly divided into 3 groups of 10: a control group (CON) receiving saline, a group receiving ALH and a group receiving ALH + RES until death after 12 weeks. The results of enhanced osseointegration in senile female rats with RES consumption were evaluated by histology, microcomputerized tomography (micro-CT), gene expression analysis and a biomechanical test. The results of this study indicated that ALH + RES showed stronger effects on the improvement of osseointegration in senile female rats with ALH consumption. The ALH + RES produced stronger effects on bone volume per total volume (BV/TV), mean trabecular thickness (Tb.Th), mean trabecular number (Tb.N) and mean trabecular separation (Tb.Sp), connective tissue density (Conn.D) and maximum push-out force for implants, and regulation of osteogenesis and bone resorption-related gene expression. These results seem to indicate that RES intervention reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats with ALH consumption. Bereits publizierte Studien belegen den schädlichen Effekt von Alkoholkonsum auf das Knochengewebe und den Knochenstoffwechsel. Resveratrol (RES) fördert die Osteoblastenproliferation und hemmt die Osteoklastenproliferation, zudem hat es positiven Einfluss auf die Knochenregeneration; die Datenlage zu Effekten von RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum ist jedoch limitiert. In der vorliegenden Studie sollte der Einfluss einer Behandlung mit RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum untersucht werden. Eingeschlossen wurden 30 weibliche Sprague-Dawley-Ratten (22 Monate alt) mit einem Gewicht von ungefähr 520 g. Alle Tiere wurden in drei Gruppen mit je 10 Individuen randomisiert; eine Kontrollgruppe (CON) erhielt Salzlösung, eine zweite Gruppe Alkohol und eine dritte Alkohol + RES bis zum Tod nach 12 Wochen. Die Resultate einer verstärkten Osseointegration bei alten weiblichen Ratten mit RES-Einnahme wurden mittels histologischer Untersuchung, Mikrocomputertomographie (Mikro-CT), Genexpressionsanalyse und eines biomechanischen Tests überprüft. In dieser Studie wurden unter Alkohol + RES stärkere Effekte auf die Verbesserung der Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum beobachtet. Alkohol + RES hatte stärkere Effekte auf Knochenvolumen pro Gesamtvolumen (BV/TV), Trabekeldicke (Tb.Th), Trabekelzahl (Tb.N), Trabekelabstand (Tb.Sp), die mittlere Bindegewebsdichte (Conn.D), die Push-out-Kraft für Implantate sowie die Regulierung der osteogenese- und knochenresorptionsbezogenen Genexpression. Diese Ergebnisse deuten darauf hin, dass eine RES-Intervention die negative Wirkung von Alkohol auf die Osseointegration hydroxylapatitbeschichteter Implantate bei alten weiblichen Ratten mit Alkoholkonsum umkehrt.
- 25 July 2019
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (5) , 664-672
Local administration with silymarin could increase osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats
As hydroxyapatite has good osteoconductive properties, it is used as coating material for the implants in cementless arthroplasty. However, its effect is not sufficient for osteoporotic bone. Silymarin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration. System administration of silymarin increases bone strength and both cancellous and cortical bone mass. The aim of this study was to confirm the effect of the local incorporation silymarin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague-Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group sham, group ovariectomized and group silymarin, and the rats from ovariectomized and sham received hydroxyapatite implants and animals belong to group silymarin received silymarin-hydroxyapatite implants until death at 12 weeks, respectively. The bilateral femurs of rats were harvested for evaluation. All treatments increased new bone formation around the surface of titanium rods and push-out force other than group ovariectomized. Compared with group ovariectomized, group silymarin showed the strongest effects on new bone formation, biomechanical strength and regulation of osteogenesis and bone resorption-related gene expression, respectively. Additionally, these are significant difference in bone formation, gene expression and push-out force was observed among treatment groups. This finding suggests that local incorporation of silymarin is useful to improve the fixation of hydroxyapatite-coated implants in ovariectomized rats.
- 25 July 2019
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 34 (5) , 664-672
Local administration with silymarin could increase osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats
As hydroxyapatite has good osteoconductive properties, it is used as coating material for the implants in cementless arthroplasty. However, its effect is not sufficient for osteoporotic bone. Silymarin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration. System administration of silymarin increases bone strength and both cancellous and cortical bone mass. The aim of this study was to confirm the effect of the local incorporation silymarin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague-Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group sham, group ovariectomized and group silymarin, and the rats from ovariectomized and sham received hydroxyapatite implants and animals belong to group silymarin received silymarin-hydroxyapatite implants until death at 12 weeks, respectively. The bilateral femurs of rats were harvested for evaluation. All treatments increased new bone formation around the surface of titanium rods and push-out force other than group ovariectomized. Compared with group ovariectomized, group silymarin showed the strongest effects on new bone formation, biomechanical strength and regulation of osteogenesis and bone resorption-related gene expression, respectively. Additionally, these are significant difference in bone formation, gene expression and push-out force was observed among treatment groups. This finding suggests that local incorporation of silymarin is useful to improve the fixation of hydroxyapatite-coated implants in ovariectomized rats.
- 10 May 2019
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 37 (6) , 1026-1035
Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration
Composite materials β-tricalcium phosphate (β-TCP) and poly-lactic-co-glycolic acid (PLGA) have achieved stable bone regeneration without cell transplantation in previous studies. Recent research shows that aspirin (ASP) has great potential in promoting bone regeneration. The objective of the present study was to incorporate PLGA into β-TCP combined with a lower single-dose local administration of ASP to enhance its in vivo biodegradation and bone tissue growth. After the creation of a rodent critical-sized femoral metaphyseal bone defect, PLGA -modified β-TCP (TP) was prepared by mixing sieved granules of β-TCP and PLGA (50:50, v/v) for medical use, then TP with dripped 50 µg/0.1 ml and 100 µg/0.1 ml aspirin solution was implanted into the defect of OVX rats until death at 8 weeks. The defected area in distal femurs of rats was harvested for evaluation by histology, micro-CT, biomechanics and real time RT-PCR. The results of our study show that a single-dose local administration of ASP combined with the local usage of TP can increase the healing of defects in OVX rats. Single-dose local administration of aspirin can improve the transcription of genes involved in the regulation of bone formation and vascularization in the defect area, and inhibits osteoclast activity. Furthermore, treatments with a higher single-dose local administration of ASP and TP showed a stronger effect on accelerating the local bone formation than while using a lower dose of ASP. The results from our study demonstrate that the combination of a single-dose local administration of ASP and β-TCP/PLGA had an additive effect on local bone formation in osteoporosis rats, and bone regeneration by PLGA/β-TCP/ASP occured in a dose-dependent manner.
- 10 May 2019
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 37 (6) , 1026-1035
Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration
Composite materials β-tricalcium phosphate (β-TCP) and poly-lactic-co-glycolic acid (PLGA) have achieved stable bone regeneration without cell transplantation in previous studies. Recent research shows that aspirin (ASP) has great potential in promoting bone regeneration. The objective of the present study was to incorporate PLGA into β-TCP combined with a lower single-dose local administration of ASP to enhance its in vivo biodegradation and bone tissue growth. After the creation of a rodent critical-sized femoral metaphyseal bone defect, PLGA -modified β-TCP (TP) was prepared by mixing sieved granules of β-TCP and PLGA (50:50, v/v) for medical use, then TP with dripped 50 µg/0.1 ml and 100 µg/0.1 ml aspirin solution was implanted into the defect of OVX rats until death at 8 weeks. The defected area in distal femurs of rats was harvested for evaluation by histology, micro-CT, biomechanics and real time RT-PCR. The results of our study show that a single-dose local administration of ASP combined with the local usage of TP can increase the healing of defects in OVX rats. Single-dose local administration of aspirin can improve the transcription of genes involved in the regulation of bone formation and vascularization in the defect area, and inhibits osteoclast activity. Furthermore, treatments with a higher single-dose local administration of ASP and TP showed a stronger effect on accelerating the local bone formation than while using a lower dose of ASP. The results from our study demonstrate that the combination of a single-dose local administration of ASP and β-TCP/PLGA had an additive effect on local bone formation in osteoporosis rats, and bone regeneration by PLGA/β-TCP/ASP occured in a dose-dependent manner.